Additionally, both GH action and increased AT mass are associated with an altered adipokine expression (Kopchick et al., 2020), and lipid and protein oxidation can modulate many obesity‐related comorbidities (Manna & Jain, 2015). The gene discussed is GH1; the disease is obesity due to melanocortin 4 receptor deficiency.